nVerses Capital »

Abcellera Biologics shares owned by nVerses Capital

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by nVerses Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.0k 1.1k 4.53

More positions owned by nVerses Capital

CenterPoint Energy (CNP)
Dropbox Cl A (DBX)
Independent Bank (INDB)
Albany Intl Corp Cl A (AIN)
Banc Of California (BANC)
Qorvo (QRVO)
Cnh Indl N V SHS (CNHI)
CMS Energy Corporation (CMS)
Marsh & McLennan Companies (MMC)
Seaboard Corporation (SEB)
HNI Corporation (HNI)
Enact Hldgs (ACT)
Donaldson Company (DCI)
Entergy Corporation (ETR)
Brighthouse Finl (BHF)

View all positions for nVerses Capital

Top funds holding Abcellera Biologics

Baillie Gifford & Co
Baker Bros. Advisors
Ing Investment Management
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
Founders Fund VII Management
Lazard Asset Management
Federated Investors
Casdin Capital
Guardian Capital Advisors
Millennium Management
Two Sigma Investments
Citadel Advisors

View all funds holding Abcellera Biologics